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Multisubunit RNA polymerase, an enzyme that accomplishes transcription in all living organisms, is a potent target for antibiot-
ics. The antibiotic streptolydigin inhibits RNA polymerase by sequestering the active center in a catalytically inactive conforma-
tion. Here, we show that binding of streptolydigin to RNA polymerase strictly depends on a noncatalytic magnesium ion which
is likely chelated by the aspartate of the bridge helix of the active center. Substitutions of this aspartate may explain different
sensitivities of bacterial RNA polymerases to streptolydigin. These results provide the first evidence for the role of noncatalytic
magnesium ions in the functioning of RNA polymerase and suggest new routes for the modification of existing and the design of
new inhibitors of transcription.
DNA-dependent RNA polymerase (RNAP) is a potent targetfor antibiotics. At present, two specific inhibitors of bacterial
RNAPs, rifampin and lipiarmycin (fidaxomicin), are in clinical
use as antibiotics, and there is still great potential for other known
inhibitors of bacterial RNAPs (or their derivatives) to be used in
the clinic in the future.
The antibiotic streptolydigin (Stl) is a derivative of 3-acetyl-
tetramic acid (Fig. 1A), and it has been known for a long time to
specifically inhibit bacterial RNAPs (1–3). Stl does not inhibit eu-
karyotic RNAPs, although their structural similarity with bacterial
RNAPs is high (4–6). Stl demonstrates only partial cross-resis-
tancewith the antibiotic rifampin, which is inwide clinical use (7),
and some other known inhibitors of bacterial RNAPs, such as
microcin J25 (8–10), CBR703 (11), and sorangicin (12). Besides
being of interest for drug development, Stl as an inhibitor of the
RNAP active center (below) is useful for a fundamental under-
standing of the catalytic mechanisms of transcription.
The crystal structures of Stl complexed with the Thermus ther-
mophilus core RNAP (13, 14) and the T. thermophilus elongation
complex (15) revealed that the antibiotic binds along the bridge
helix (BH) about 20 Å away from the catalytic Mg2 ions of the
active center (Fig. 1B), which participate in catalysis of all the
reactions performed by the RNAPs (16, 17). Structural and bio-
chemical analyses showed that Stl freezes the unfolded conforma-
tion of a flexible domain of the active center, the trigger loop (TL)
(Fig. 1B). The TL was later shown to be essential for catalysis of all
reactions by the active center (18–20), explaining the ability of Stl
to inhibit all RNAP catalytic activities (13).
The two largest subunits,  and =, are involved in the binding
of Stl (13, 21–24). The binding site is formed on the “DNA side” of
the bridge helix (Fig. 1B); the streptololmoiety of Stl interactswith
regions STL1 (positions 538 to 552 of the second-largest subunit;
538–552 [Escherichia colinumbering]) and STL2 (557–576) and the
N-terminal portion of the BH (=769–788) (13), while the tetramic
acid groups interact with the central portion of the BH (=789–795)
andwith the ordered segment of theTL (13). The acetamide group
of the tetramic acidmoiety of Stl and=D792 of the BH are critical
for Stl binding (13, 24). Here we provide evidence that the binding
of Stl to RNAP strictly requires a noncatalytic Mg2 ion, which
apparently bridges the Stl tetramic acid moiety to =D792 of the
BH. To the best of our knowledge, this is the first direct evidence
for the role of noncatalytic Mg2 ions in RNAP functioning.
MATERIALS AND METHODS
WTandmutantRNAPs.Recombinantwild-type (WT) andmutantTher-
mus aquaticus core RNAPs were constructed and purified as described
previously (25).
Transcription essays. Elongation complexes (ECs) were assembled
with WT and mutant (H936A/R933A and M932A [E. coli numbering])
RNAPs as described previously (18) and placed in transcription buffer con-
taining 40 mM KCl and 20 mM Tris (pH 7.9). Prior to complex assembly,
RNA was 32P labeled at the 5= end by using [-32P]ATP (PerkinElmer). All
reactions were carried out at 40°C. Stl (Sigma) with or without 10 mM
MgCl2 was added before the reactions for 10 min at 40°C. Elongation
reactions were initiated by addition of 1 mM GTP or 1 mM GTP with 10
mM MgCl2; endonucleolytic cleavage reactions were initiated by the ad-
dition of 10 mMMgCl2. Reactions were stopped by the addition of form-
amide-containing buffer, and products were analyzed as described previ-
ously (18). Fast kinetics experiments were performed as described
previously (18). The kinetics data that were described well by a single
exponent were fitted into a single-exponent equation using the nonlinear
regression procedure in SigmaPlot software. Plots were normalized to the
predictedmaximum, which was taken as 100. The rates were then fitted in
a hyperbolic equation to determine the Ki[Stl]. When the kinetics was
described by a double exponent, the predictedmaximaof the fast fractions
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FIG1 Inhibition of elongation and intrinsic cleavage of RNAby Stl. (A)Chemical structure of Stl. (B)Close-up viewof Stl bound in the active center in the crystal
structure of the T. thermophilus RNAP elongation complex (Protein Data Bank [PDB] code 2PPB). The  subunit was removed for clarity. The amino acids of
the TL (orange), mutated in this study, are shown as orange sticks. (C and D) Schemes of the elongation complexes (EC1 and EC2) used and representative
phosphorimaging scans of the products of the reactions separated in denaturing polyacrylamide gels are shown above the plots. T, template strands; NT,
nontemplate strands. RNA (red) was radiolabeled at the 5= end. (C) Kinetics of GTP incorporation (1 mM GTP and 10 mM Mg2) in EC1 in the presence of
different concentrations of Stl. (D) Kinetics of intrinsic (endonucleolytic) cleavage (10mMMgCl2) in EC2 in the presence of different concentrations of Stl. Note
that the addition of nonsaturating Stl before the reactants results in two fractions (fast and slow) of the elongation complexes. (E to G). Kinetics of NMP
incorporation in the presence of different concentrations of Stl, preincubated with or without Mg2, were fitted in a single-exponent equation. Note the clearly
double exponential nature of the kinetics data in panel E.
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were used for the fit to determine the Stl concentration that inhibited half
of the complexes (equivalent of the Ki).
Mg2binding to Stl.The spectra of Stl were recordedusing aUV160U
UV-visible (UV-Vis) recording spectrophotometer (Shimadzu Scientific
Instruments, Inc.) in a fused silica measuring cell in the presence of the
indicated concentrations of the MgCl2 in 20 mMHEPES buffer (pH 8.0).
RESULTS
In order to investigate the details of the effects of Stl on RNAP
active center functioning, we used artificially assembled elonga-
tion complexes (ECs). These complexes are assembled with Ther-
mus aquaticus RNAP, fully complementary synthetic template
and nontemplate DNA oligonucleotides, and an RNA oligonucle-
otide (Fig. 1C and D). The complexes are indistinguishable from
“native” elongation complexes obtained by transcription from a
promoter (19, 26, 27). We analyzed the kinetics of nucleoside
monophosphate (NMP) addition in the presence of different con-
centrations of Stl in the elongation complex EC1, containing a
13-nucleotide-longRNA (Fig. 1C).Note that Stl was preincubated
with the EC for 10 min before the addition of nucleoside triphos-
phate (NTP) with Mg2, which initiated synthesis. Curiously, at
lower concentrations of Stl, we observed a clear separation of the
kinetics curve into two phases, fast and slow (Fig. 1C and E, the
latter as an example of the fit of the data into a single-exponent
equation). At higher concentrations, the divisionwas less obvious,
and the kinetics can be described by a single-exponent equation
(Fig. 1F).
Next, we tested the effects of increasing concentrations of Stl
on the hydrolysis of the phosphodiester bond, a reaction also cat-
alyzed by the RNAP active center. As seen from Fig. 1D, Stl also
divided the ECs into sensitive (slow) and resistant (fast) fractions.
Interestingly, however, the concentration of Stl required to inhibit
half of the ECs (the inhibition constant Ki cannot be used in this
case, given that the kinetics cannot be described by a single-expo-
nent equation) during hydrolysis was 8 times lower than that
during NTP addition (Table 1).
The rate of phosphodiester bondhydrolysis ismuch lower than
that ofNMP incorporation (Table 1).We hypothesized that, upon
the start of the reaction by addition of reactants, Stl requires time
to manifest its inhibitory activity (note that complexes were pre-
incubated with Stl before the start of the reaction), which would
explain the more successful inhibition of the slower reaction of
hydrolysis by Stl. To test this hypothesis, we analyzed the inhibi-
tion of RNA extension by mutant RNAPs (=H936A/R933A and
=M932A) with strongly decreased rates of phosphodiester bond
formation (18). =H936/R933 of the TL participates in the catal-
ysis of the phosphodiester bond formation by stabilizing the tran-
sition state of the reaction (18). =M932 of the TL stacks on the
base of the NTP bound in the active center and stabilizes the TL in
the folded state, which is required for catalysis (18). Accordingly,
the alanine substitutions of either =H936/R933 or =M932 dras-
tically slow downNMP incorporation, although through different
mechanisms (18). Neither of these amino acids participates in the
Stl binding (Fig. 1B) (13, 18). We argued that, upon addition of
Mg2 and NTP, Stl would have enough time to inhibit ECs before
the reaction had started. Indeed, as shown in Table 1, the half-
inhibitory concentrations of Stl for NMP incorporation by
=H936A/R933A and =M932A RNAPs were 15 to 20 times lower
than that for WT RNAP. Given that the mutations slow down the
reaction via different ways, the result suggests that the slowness of
the mutant RNAPs leads to their Stl sensitivity. Note also a corre-
lation between the inhibitory effects of Stl and the rates of the
reactions in Table 1.
The above results suggest that the inhibition by Stl begins to
establish itself only after the addition of the reactants. The only
common component added to start the NMP incorporation and
hydrolysis is Mg2. We hypothesized thatMg2 is required for Stl
binding to RNAP. According to this proposal, when Mg2 is
added together withNTP, Stl does not have time to bind to allWT
ECs before the reaction in them has already finished, thus giving
birth to the fast and slow fractions of ECs. The hypothesis predicts
that the preincubation of ECs with Mg2 and Stl before the addi-
tion of NTPs would result inmore efficient inhibition. To test this
prediction, we preincubated WT ECs with Stl and Mg2 prior to
the addition of NTP (a similar experiment cannot be duplicated
for phosphodiester bond hydrolysis because the addition ofMg2
would initiate the reaction). Indeed, as seen from Fig. 1G, the
kinetics in the presence of even small concentrations of Stl can be
described by a single-exponent equation. Accordingly, when Stl
was preincubatedwithMg2, the half-inhibitory concentration of
Stl was15 times lower than that whenMg2was added together
with NTP (Table 1). We therefore conclude that Stl binding to
RNAP requires the Mg2 ion.
We attempted to directly visualize if Stl can bindMg2. Stl has
a distinct UV absorption spectrum. As seen from Fig. 2A, the
spectrum undergoes marked changes upon titration with Mg2.
Together with the above results, this suggests that Stl may indeed
chelate Mg2, although whether the observed change in the Stl
spectrum indeed accounts for Mg2 binding requires further in-
vestigation.
DISCUSSION
The principal finding of this study is that Stl requires Mg2 to
establish its inhibitory effect on RNAP. To the best of our knowl-
edge, this is the first observation of a small-molecular-weight in-
hibitor of RNAP requiring an additional agent for its action. For
example, the inhibitor tagetitoxin also binds in the vicinity of the
active center and is known to chelate Mg2 but does not require
addition of external Mg2, while the kinetics of NMP addition in
the presence of tagetitoxin does not exhibit behavior similar to
that observed with Stl (Fig. 1C and E) (28). The apparent affinity
of Stl for Mg2, as can be deduced from our titration experiment
(Fig. 2A), is around 1 mM, which is close to the Mg2 concentra-
TABLE 1 Correlation of the rate of the reaction and efficiency of
inhibition by Stl preincubated with or without Mg2
RNAP
Reaction
(kobs) (s
1) Ki[Stl] (g/ml)
WT
1 mM GTP incorporation
Mg2 100 19 8.32 1.08a
Mg2 0.53 0.036
Hydrolysis,Mg2 0.049 0.007 1.1 0.15a
H936A/R933A mutant
1 mM GTP incorporation,Mg2 0.037 0.004 0.49 0.14
M932A mutant
1 mM GTP incorporation,Mg2 0.028 0.003 0.39 0.06
a Half-inhibitory concentration determined from the proportion of the fast fraction.
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tion in the bacterial cell. It is likely, however, that RNAP also
provides binding determinants for the Mg2 ion. Stl binds too
far from the catalytic Mg2 ions of the active site and is unlikely
be influenced by them (Fig. 1B). However, careful examination
of the crystal structure of the elongation complex bound to Stl
reveals an electron density that is unaccounted for between the
hydroxyl of the tetramic acid moiety of Stl and =D792 of the
BH, which can be attributed to Mg2 (15) (Fig. 2B). This ob-
servation is consistent with the fact that the Stl analog tiranda-
mycin, which lacks the acetamide group, is a significantly
weaker inhibitor than Stl (29). Also, there are some other ob-
servations that point to the importance of the =792 residue in
Stl binding. Mutation =D792G confers strong resistance to Stl
(24). Furthermore, RNAPs that have aspartic acid at position
=792 (including T. thermophilus and T. aquaticus RNAPs) are
much more sensitive to Stl than the RNAPs that have aspara-
gine at this position (including E. coli RNAP). Finally, the
=N792D substitution in E. coli RNAP leads to a significant en-
hancement of the enzyme sensitivity to Stl (13). Taken together
with our results, these facts suggest that Mg2 bridges =N792D
and Stl, leading to tighter binding of the latter. This scenario also
raises an intriguing possibility of a role for noncatalyticMg2 ions
in the functioning/inhibition of the enzyme.
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